Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia

Author:

Tettamanti Sarah1ORCID,Rotiroti Maria Caterina1,Giordano Attianese Greta Maria Paola12,Arcangeli Silvia1,Zhang Ronghua3,Banerjee Priyanka34,Galletti Giovanni35,McManus Sheighlah36,Mazza Massimiliano7,Nicolini Fabio7,Martinelli Giovanni7,Ivan Cristina3ORCID,Veliz Rodriguez Tania8,Barbaglio Federica8,Scarfò Lydia8910,Ponzoni Maurilio91011,Wierda William12,Gandhi Varsha3,Keating Michael12,Biondi Andrea1ORCID,Caligaris-Cappio Federico813,Biagi Ettore114,Ghia Paolo8910,Bertilaccio Maria Teresa Sabrina3ORCID

Affiliation:

1. Centro Ricerca Tettamanti, Clinica Pediatrica, Università Milano Bicocca, Osp. San Gerardo/Fondazione MBBM, Monza, Italy

2. Ludwig Institute for Cancer Research, Lausanne, Switzerland

3. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

4. P.B. is presently at Texas A&M University Health Science Center, Bryan, TX, USA

5. Humanitas Clinical and Research Center, Rozzano, Italy

6. The University of Texas MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences (GSBS), Houston, TX, USA

7. Immunotherapy, Cell Therapy and Biobank (ITCB), IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori, Meldola, Italy

8. Division of Experimental Oncology, IRCCS San Raffaele Hospital, Milan, Italy

9. Università Vita-Salute San Raffaele, Milan, Italy

10. Strategic Research Program on CLL, IRCCS San Raffaele Hospital, Milan, Italy

11. Pathology Unit, IRCCS San Raffaele Hospital, Milan, Italy

12. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

13. Scientific Director of AIRC (Associazione Italiana per la Ricerca sul Cancro), Milan, Italy

14. BMS/Celgene, Boudry, Switzerland

Funder

Celgene

CLL Global Research Foundation

IG 2015

Quelli che con Luca

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3